Re. Delius et al., METABOLIC INHIBITION POTENTIATES OXIDANT-MEDIATED INJURY OF THE ENDOTHELIAL CYTOSKELETON, The Journal of surgical research, 64(1), 1996, pp. 79-88
The aim of this study was to determine if exposure of cells to oxidant
s and metabolic inhibition, conditions which are present during ischem
ia-reperfusion, act synergistically to produce cytoskeletal disruption
. Adherent bovine pulmonary artery endothelial cells were subjected to
metabolic inhibition by incubating the cells in glucose-free buffer c
ontaining 650 nM oligomycin for 2 hr. Cells were rescued from metaboli
c inhibition by washing the cells with buffer containing 5.5 mM glucos
e and were simultaneously exposed to 0, 25, 100, or 5000 mu M H2O2. At
various time points during recovery from metabolic inhibition the mic
rofilaments and microtubules were stained for microscopic evaluation.
Intracellular ATP levels were determined by the luciferin/luciferase a
ssay. Cells that were not metabolically inhibited showed minimal micro
filament disruption at lower doses of H2O2. Cells that were subjected
to metabolic inhibition but not exposed to H2O2 showed microfilament d
isruption after 2 hr of metabolic inhibition, but normal microfilament
architecture was seen in over 95% of the cells by 1 hr after recovery
from metabolic inhibition. Cells that were metabolically inhibited an
d then exposed to doses of H2O2 as low as 25 mu M showed marked microf
ilament disruption at 1 and 2 hr after the metabolic inhibition was re
lieved, The microtubules were distorted, but did not depolymerize exce
pt when exposed to concentrations of H2O2 greater than or equal to 500
0 mu M. Metabolic inhibition appeared to selectively potentiate the ef
fect of subsequent oxidant exposure and the potentiation largely affec
ted microfilament architecture with secondary effects on microtubule m
orphology and endothelial cell shape. (C) 1996 Academic Press, Inc.